{
    "Trade/Device Name(s)": [
        "Audit\u00ae MicroControls\u2122 Linearity LQ Cystatin-C"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K143571",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130157"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "December 12, 2014",
    "Summary Letter Received Date": "December 17, 2014",
    "Submission Date": "December 12, 2014",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cystatin-C"
    ],
    "Specimen Type(s)": [
        "Human Based Serum",
        "Bovine Based Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Beckman Immage"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Linearity Set"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u00ae MicroControls\u2122 Linearity LQ Cystatin-C assayed QC material intended to verify linearity and calibration for Cystatin-C assays",
    "Indications for Use Summary": "Intended to simulate human patient samples for use in determining linearity, calibration verification, and verification of reportable range for Cystatin-C analyte",
    "fda_folder": "Clinical Chemistry"
}